Qi Cao Selected Research

Qi Cao Research Topics

Disease

78	Neoplasms (Cancer) 05/2024 - 07/2006
41	Prostatic Neoplasms (Prostate Cancer) 05/2024 - 09/2003
27	Inflammation (Inflammations) 01/2024 - 03/2004
21	Fibrosis (Cirrhosis) 03/2023 - 10/2003
17	Neoplasm Metastasis (Metastasis) 01/2022 - 11/2006
16	Infections 01/2023 - 02/2014
14	Renal Cell Carcinoma (Grawitz Tumor) 11/2020 - 01/2017
12	Bites and Stings (Sting) 12/2023 - 01/2021
9	Carcinogenesis 01/2024 - 11/2005
8	Liver Cirrhosis (Hepatic Cirrhosis) 08/2023 - 04/2002
8	Breast Neoplasms (Breast Cancer) 12/2022 - 09/2003
6	Alcoholic Fatty Liver 04/2024 - 03/2004
6	Atherosclerosis 08/2022 - 01/2017
6	Proteinuria 01/2022 - 09/2008
6	Kidney Diseases (Kidney Disease) 01/2020 - 07/2013
5	Cardiovascular Diseases (Cardiovascular Disease) 08/2022 - 01/2018
5	Insulin Resistance 01/2019 - 03/2004
4	Obesity 10/2023 - 01/2017
4	Polycystic Ovary Syndrome (Syndrome, Stein-Leventhal) 09/2023 - 10/2016
4	Wounds and Injuries (Trauma) 11/2022 - 11/2006
4	Lung Neoplasms (Lung Cancer) 01/2022 - 07/2009
4	Necrosis 01/2022 - 05/2002
4	Hypoxia (Hypoxemia) 01/2022 - 04/2009
4	Glomerulonephritis 01/2022 - 12/2007
4	Pneumonia (Pneumonitis) 01/2021 - 11/2017
4	Reperfusion Injury 01/2021 - 01/2018
4	Fatty Liver 01/2020 - 03/2008
4	Kidney Neoplasms (Kidney Cancer) 01/2019 - 01/2017
4	Alcoholic Liver Diseases (Alcoholic Liver Disease) 01/2012 - 12/2002
4	Ovarian Neoplasms (Ovarian Cancer) 04/2009 - 07/2006
3	Carcinoma (Carcinomatosis) 02/2024 - 04/2010
3	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 06/2023 - 04/2015
3	Acute Kidney Injury (Acute Renal Failure) 04/2022 - 12/2006
3	Chronic Renal Insufficiency 01/2020 - 05/2012
3	Glioma (Gliomas) 11/2019 - 12/2015
3	Focal Segmental Glomerulosclerosis (Glomerulosclerosis, Focal) 11/2019 - 12/2007
3	Nephrosis 10/2013 - 06/2008

Drug/Important Bio-Agent (IBA)

31	Proteins (Proteins, Gene)FDA Link 02/2024 - 09/2003
24	CytokinesIBA 12/2023 - 05/2002
18	Biomarkers (Surrogate Marker)IBA 06/2023 - 11/2008
16	Messenger RNA (mRNA)IBA 01/2021 - 03/2004
12	DNA (Deoxyribonucleic Acid)IBA 10/2023 - 02/2013
9	AndrogensIBA 11/2023 - 08/2007
9	Antiviral Agents (Antivirals)IBA 10/2023 - 01/2021
9	RNA (Ribonucleic Acid)IBA 06/2023 - 07/2011
8	LipidsIBA 02/2024 - 01/2018
8	Long Noncoding RNAIBA 07/2021 - 07/2011
7	Phosphotransferases (Kinase)IBA 10/2023 - 07/2006
7	Glucose (Dextrose)FDA LinkGeneric 04/2022 - 01/2017
7	Androgen Receptors (Androgen Receptor)IBA 01/2021 - 10/2009
6	InterferonsIBA 04/2024 - 01/2022
6	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2023 - 06/2008
6	Ethanol (Ethyl Alcohol)IBA 01/2022 - 12/2002
6	CateninsIBA 01/2021 - 01/2016
6	CollagenIBA 01/2020 - 01/2006
6	MicroRNAs (MicroRNA)IBA 04/2019 - 06/2011
6	Insulin (Novolin)FDA Link 01/2019 - 03/2004
6	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 10/2018 - 12/2002
5	ChromatinIBA 02/2024 - 01/2013
5	Hormones (Hormone)IBA 09/2023 - 11/2008
5	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 01/2023 - 03/2010
5	VaccinesIBA 09/2022 - 12/2008
5	Therapeutic UsesIBA 01/2021 - 09/2010
5	Transcription Factors (Transcription Factor)IBA 01/2020 - 07/2010
5	AntigensIBA 01/2019 - 02/2013
4	Indicators and Reagents (Reagents)IBA 02/2024 - 10/2018
4	Peptides (Polypeptides)IBA 11/2023 - 05/2020
4	Interleukin-6 (Interleukin 6)IBA 06/2023 - 04/2015
4	Small Interfering RNA (siRNA)IBA 01/2023 - 04/2009
4	Estrogen ReceptorsIBA 12/2022 - 06/2009
4	EnzymesIBA 12/2022 - 03/2008
4	AntioxidantsIBA 11/2022 - 01/2006
4	Estrogens (Estrogen)FDA Link 01/2022 - 11/2006
4	Transforming Growth Factors (Transforming Growth Factor)IBA 01/2021 - 01/2014
4	Polycomb-Group ProteinsIBA 10/2020 - 09/2003
4	Sunitinib (Sutent)FDA Link 09/2020 - 01/2017
4	LipopolysaccharidesIBA 01/2020 - 05/2012
3	InflammasomesIBA 12/2023 - 01/2018
3	MethyltransferasesIBA 11/2023 - 11/2019
3	cyclic guanosine monophosphate-adenosine monophosphateIBA 10/2023 - 01/2022
3	enzalutamideIBA 10/2023 - 01/2018
3	Interleukin-33IBA 11/2022 - 01/2018
3	Reactive Oxygen Species (Oxygen Radicals)IBA 11/2022 - 01/2019
3	Amino Acids FDA Link 01/2022 - 02/2009
3	fucoidanIBA 09/2021 - 03/2019
3	ICG 001IBA 01/2021 - 01/2018
3	ChemokinesIBA 11/2019 - 12/2008
3	Complement System Proteins (Complement)IBA 11/2018 - 06/2012
3	NF-kappa B (NF-kB)IBA 01/2018 - 07/2006
3	Matrix Metalloproteinases (MMPs)IBA 05/2017 - 01/2007
3	Toll-Like Receptors (Toll-Like Receptor)IBA 01/2017 - 07/2009
3	CreatinineIBA 01/2015 - 06/2011
3	Proto-Oncogene Proteins c-etsIBA 10/2012 - 01/2008
3	Progestins (Progestagens)IBA 04/2009 - 11/2006
3	Cytochrome P-450 CYP2E1 (CYP2E1)IBA 10/2007 - 07/2005

Therapy/Procedure

29	Therapeutics 05/2024 - 12/2007
11	Castration 01/2024 - 06/2017
7	Immunotherapy 01/2024 - 01/2018
4	Chinese Traditional Medicine (Traditional Chinese Medicine) 12/2022 - 01/2017
3	Drug Therapy (Chemotherapy) 10/2021 - 06/2017